Analysis

Teva Is Hurting Its Chances of Emerging From the Ruins

Now more than ever the pharmaceutical giant needs a CEO who will rehabilitate the company - but with a package worth $9.2 million, the temporary CEO has no incentive to give up his job

Yoram Gabison
Yoram Gabison
Send in e-mailSend in e-mail
Interim Teva CEO Prof. Yitzhak Peterburg, 2015.
Interim Teva CEO Prof. Yitzhak Peterburg, 2015.Credit: Jonathan Bloom

Comments